Clinical Trial Update: S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating S-1 in combination with gemcitabine and erlotinib for advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Pancreas Neoplasms | Phase 2 | Status: COMPLETED